Teclistamab in Previously Treated AL Amyloidosis

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 21, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2028

Conditions

AL Amyloidosis

Interventions

DRUG

Teclistamab (Tec)

Teclistamab will be administered via a subcutaneous injection

Trial Locations (1)

RECRUITING

Peking Union Medical College Hospital, Beijing

All Listed Sponsors

lead

Peking Union Medical College Hospital

OTHER